Charles H. Maris

2.5k total citations
13 papers, 2.0k citations indexed

About

Charles H. Maris is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Charles H. Maris has authored 13 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 6 papers in Oncology and 1 paper in Epidemiology. Recurrent topics in Charles H. Maris's work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (7 papers). Charles H. Maris is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (7 papers). Charles H. Maris collaborates with scholars based in United States, France and Taiwan. Charles H. Maris's co-authors include Charles G. Drake, Edward L. Hipkiss, Drew M. Pardoll, Monica V. Goldberg, Derese Getnet, Joseph F. Grosso, Timothy Harris, Tullia C. Bruno, Joshy Jacob and Christopher J. Thoburn and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Charles H. Maris

13 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles H. Maris United States	10	1.6k	1.2k	284	152	107	13	2.0k
Linhua Vatan United States	9	1.8k 1.1×	1.1k 0.9×	355 1.3×	75 0.5×	137 1.3×	10	2.3k
Junrong Xia United States	6	1.6k 1.0×	842 0.7×	304 1.1×	78 0.5×	60 0.6×	6	2.0k
Sonia Pastor France	14	946 0.6×	857 0.7×	229 0.8×	96 0.6×	93 0.9×	22	1.4k
Yukiko Kiniwa Japan	15	1.7k 1.1×	872 0.8×	478 1.7×	150 1.0×	74 0.7×	55	2.4k
Daisuke Sugiura Japan	14	1.1k 0.7×	1.2k 1.0×	302 1.1×	133 0.9×	74 0.7×	21	1.7k
Katia Beider Israel	26	1.1k 0.7×	1.2k 1.0×	667 2.3×	110 0.7×	88 0.8×	62	2.2k
T Honjo Japan	13	747 0.5×	786 0.7×	348 1.2×	139 0.9×	80 0.7×	17	1.5k
Satdip Kaur United Kingdom	7	1.3k 0.8×	845 0.7×	221 0.8×	74 0.5×	211 2.0×	10	1.9k
Joë-Marc Chauvin United States	10	1.3k 0.8×	1.3k 1.1×	326 1.1×	157 1.0×	65 0.6×	16	1.8k
Dennis O. Adeegbe United States	18	1.2k 0.8×	845 0.7×	487 1.7×	232 1.5×	72 0.7×	31	1.9k

Countries citing papers authored by Charles H. Maris

Since Specialization

Citations

This map shows the geographic impact of Charles H. Maris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles H. Maris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles H. Maris more than expected).

Fields of papers citing papers by Charles H. Maris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles H. Maris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles H. Maris. The network helps show where Charles H. Maris may publish in the future.

Co-authorship network of co-authors of Charles H. Maris

This figure shows the co-authorship network connecting the top 25 collaborators of Charles H. Maris. A scholar is included among the top collaborators of Charles H. Maris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles H. Maris. Charles H. Maris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Xie, Ying, Akgül Akpınarlı, Charles H. Maris, et al.. (2010). Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma. The Journal of Experimental Medicine. 207(3). 651–667. 343 indexed citations

Antony, Paul A., Akgül Akpınarlı, Charles H. Maris, et al.. (2010). Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma (131.12). The Journal of Immunology. 184(Supplement_1). 131.12–131.12. 3 indexed citations

Getnet, Derese, Charles H. Maris, Edward L. Hipkiss, et al.. (2009). Tumor Recognition and Self-Recognition Induce Distinct Transcriptional Profiles in Antigen-Specific CD4 T Cells. The Journal of Immunology. 182(8). 4675–4685. 32 indexed citations

Sfanos, Karen S., Tullia C. Bruno, Charles H. Maris, et al.. (2008). Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg Skewing. Clinical Cancer Research. 14(11). 3254–3261. 345 indexed citations

Harris, Timothy, Joseph F. Grosso, Hung‐Rong Yen, et al.. (2007). Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity. The Journal of Immunology. 179(7). 4313–4317. 484 indexed citations

Goldberg, Monica V., Charles H. Maris, Edward L. Hipkiss, et al.. (2007). Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood. 110(1). 186–192. 150 indexed citations

Grosso, Joseph F., Timothy Harris, Charles H. Maris, et al.. (2007). LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. Journal of Clinical Investigation. 117(11). 3383–3392. 433 indexed citations

Zhang, Benyue, Charles H. Maris, Juergen Foell, et al.. (2007). Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. Journal of Clinical Investigation. 117(10). 3029–3041. 48 indexed citations

Maris, Charles H., Craig P. Chappell, & Joshy Jacob. (2007). Interleukin-10 plays an early role in generating virus-specific T cell anergy. BMC Immunology. 8(1). 8–8. 43 indexed citations

10.

Drake, Charles G., Tullia C. Bruno, Timothy Harris, et al.. (2006). Blocking the regulatory T cell molecule LAG-3 augments in vivo anti-tumor immunity in an autochthonous model of prostate cancer. Journal of Clinical Oncology. 24(18_suppl). 2573–2573. 1 indexed citations

11.

Maris, Charles H., Joseph D. Miller, John D. Altman, & Joshy Jacob. (2003). A Transgenic Mouse Model Genetically Tags All Activated CD8 T Cells. The Journal of Immunology. 171(5). 2393–2401. 23 indexed citations

12.

Garg, Sanjay, Alp E. Oran, Shin Sasaki, et al.. (2003). Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nature Immunology. 4(9). 907–912. 107 indexed citations

13.

Maris, Charles H., Joshy Jacob, & David Baltimore. (2000). reply: Investigating T-cell memory. Nature. 407(6800). 40–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact